(Gln22) -Amyloid β-Protein (1-42)

(Gln22) -Amyloid β-Protein (1-42) is a Dutch mutation (E22Q) form of β-Amyloid (1-42) (HY-P1363) . (Gln22) -Amyloid β-Protein (1-42) exhibits enhanced fibrillogenic and pathogenic properties[1].

Product Specifications

CAS Number

[147335-12-4]

UNSPSC

12352209

Target

Amyloid-β

Type

Peptides

Related Pathways

Neuronal Signaling

Applications

Neuroscience-Neurodegeneration

Field of Research

Neurological Disease

Assay Protocol

https://www.medchemexpress.com/gln22-amyloid-β-protein-1-42.html

Solubility

H2O

Smiles

C[C@@H](C(O)=O)NC([C@H]([C@@H](C)CC)NC([C@H](C(C)C)NC([C@H](C(C)C)NC(CNC(CNC([C@H](C(C)C)NC([C@H](CCSC)NC([C@H](CC(C)C)NC(CNC([C@H]([C@@H](C)CC)NC([C@H]([C@@H](C)CC)NC([C@H](C)NC(CNC([C@H](CCCCN)NC([C@H](CC(N)=O)NC([C@H](CO)NC(CNC([C@H](C(C)C)NC([C@H](CC(O)=O)NC([C@H](CCC(N)=O)NC([C@H](C)NC([C@H](CC1=CC=CC=C1)NC([C@H](CC2=CC=CC=C2)NC([C@H](C(C)C)NC([C@H](CC(C)C)NC([C@H](CCCCN)NC([C@H](CCC(N)=O)NC([C@H](CC3=CNC=N3)NC([C@H](CC4=CNC=N4)NC([C@H](C(C)C)NC([C@H](CCC(O)=O)NC([C@H](CC5=CC=C(C=C5)O)NC(CNC([C@H](CO)NC([C@H](CC(O)=O)NC([C@H](CC6=CNC=N6)NC([C@H](CCCNC(N)=N)NC([C@H](CC7=CC=CC=C7)NC([C@H](CCC(O)=O)NC([C@H](C)NC([C@H](CC(O)=O)N)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O

Molecular Formula

C203H312N56O59S

Molecular Weight

4513.05

References & Citations

[1]Davis J, et al. Early-onset and robust cerebral microvascular accumulation of amyloid beta-protein in transgenic mice expressing low levels of a vasculotropic Dutch/Iowa mutant form of amyloid beta-protein precursor. J Biol Chem. 2004 May 7;279 (19) :20296-306.